Abstract:Epigenetics has been known to mediate genetic risks and regulate gene expression in complex diseases. Due to substantial epigenetic variation, particularly DNA methylation, is tissue specific, sample accessibility has been one of the major road blockers in epigenetic research for human brain disorders. However, previous studies have shown that DNA methylation can also be significantly regulated by genetics and such effect is relatively consistent cross tissues. A better understanding of this genetic and epigenetic relationship can be very beneficial for the investigation of diseases pathology. In this work, we conducted a comprehensive analysis of genetic influence on DNA methylation across brain and peripheral tissues, characterized genetics and their target CpGs, and their functional relevance to psychiatric diseases. We performed a genome-wide methylation quantitative trait loci (meQTLs) analysis on postmortem brain prefrontal cortex, whole blood and saliva. Cis-acting SNP-methylation pairs (distance < 20k base pairs) were matched across tissues. The overlap of meQTLs and targeted CpG sites in different tissues were evaluated by a Fisher exact test. Cis-effect size among tissues was also compared. While focusing on cross tissue consistent SNP-methylation effects, enrichment tests were applied to explore the genomic distribution of targeted CpG sites, their annotation in functional pathways and diseases, and their enrichment in the CpG set with high brain-blood correspondence. In addition, we tested the enrichment of cross-tissue meQTLs in risk loci of five major psychiatric disorders reported by large-scale genome-wide association studies, and further explored their overlap with cross-tissue expression QTLs. Finally, we constructed cross-tissue consensus co-methylation networks for the meQTL targeted CpG sites. We found significant overlap of meQTLs and targeted CpGs cross tissue (34%-73%). MeQTLs in blood showed the strongest cis-effect followed by brain and saliva regardless of direction of effect. Cross-tissue meQTL targeted CpGs were highly distributed on CpG island shore regions (OR: odds ratio = 1.3, P = 2.8e-99) and had a much higher probability being blood brain correspondent than non-meQTL target CpGs (OR=6.6). Cross-tissue meQTLs showed significant enrichment in risk loci of five major psychiatric disorders (OR: odds ratio = [1.65 - 5.42]). In addition, these cross-tissue meQTLs also enriched significantly in cross-tissue eQTLs (OR = 16.21), where 351 SNPs were meQTl, eQTL, and carried significant schizophrenia risk, mainly from regions 6p21.1 – 6p24.3. Finally, we found more similar co-methylation network structure between brain and blood than brain and saliva, and identified one consensus module showing significant schizophrenia risk (Z= -4.54, p = 5.5e-6). Results show strong cross-tissue similarity of meQTLeffects, especially between brain and blood, and their significant enrichment in psychiatric disorders, supporting the surrogate role of peripheral tissues in studying pathology of genetic effect on brain disorders through methylation.

Network Modules Linking Expression and Methylation in Prefrontal Cortex of Schizophrenia

DNA Methylation in Schizophrenia: Progress and Challenges

Chromatin Profiling in Human Neurons Reveals Aberrant Roles for Histone Acetylation and BET Family Proteins in Schizophrenia

Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia

Hyper-Coordinated DNA Methylation is Altered in Schizophrenia and Associated with Brain Function

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients

Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia

Advancements in the Underlying Pathogenesis of Schizophrenia: Implications of DNA Methylation in Glial Cells

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.

Two Gene Co-expression Modules Differentiate Psychotics and Controls

Epigenetic Regulation in Schizophrenia: Focus on Methylation and Histone Modifications in Human Studies

Brain transcriptional regulatory architecture and schizophrenia etiology converge between East Asian and European ancestral populations

An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation

Consensus molecular environment of schizophrenia risk genes in coexpression networks shifting across age and brain regions

Network-based Analysis on the Genes and Their Interactions Reveals Link Between Schizophrenia and Alzheimer's Disease.

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

CHARACTERIZATION OF CROSS-TISSUE Mqtl EFFECTS AND THEIR RELEVANCE IN PSYCHIATRIC DISORDERS

Integrated Transcriptome Analysis Reveals Novel Molecular Signatures for Schizophrenia Characterization.